Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Scientists probe immune link to migraine in autoimmune patients

NCT ID NCT06426316

First seen Nov 20, 2025 · Last updated Jun 19, 2026 · Updated 36 times

Summary

This study looks at how immune cells and inflammatory molecules differ in people with migraine, especially those who also have autoimmune diseases like multiple sclerosis, rheumatoid arthritis, or endometriosis. Researchers will compare blood samples from 396 women to measure regulatory T cells and cytokines. The goal is to better understand the biological mechanisms behind migraine, which could eventually lead to new treatments.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • CHU de Clermont-Ferrand - Service de Neurologie

    RECRUITING

    Clermont-Ferrand, AURA, 63000, France

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could clarify why migraine is more common in people with certain autoimmune diseases, pointing toward new treatment targets.

What could go wrong

This is an observational study, not a treatment trial. It will not directly test any therapy, and results may not lead to immediate clinical changes.

Conditions

The condition(s) this trial relates to.

autoimmune disease Crohn disease endometriosis lupus erythematosus migraine disorder multiple sclerosis Pain rheumatoid arthritis systemic lupus erythematosus type 1 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.